tada ... actually just spit balling. I don't really see Hepalink as a problem either, just a very large investor with lots of potential clout, and designs on Asia business interestes at least. I also think they would likely be VERY happy with a huge windfall, and potentially Asia manufacturing, and distribution rights. Most markets like China are best served within internal established distribution channels and sound relationships, agreed ... my only further question/consideration for Hepalink "possibly" taking on a bigger role was because of the introduction of Ori into the mix - which could make for some interesting discussion/possibilities for some possible contemplations/scenarios, or window dressing for negotiating leverage with BP. 

With today's news, my mind is switching gears to the chess board, and potential "plays" ... perhaps it is better to just go back into a hole and hibernate a bit longer waiting further news, with the comfort and security of today's meal stilll warm in my belly, until spring arrives haha :)

... "something" has to happen soon, in order to get the train further down the tracks. Like others, hopeful for a buy out rather than a partnership. Seems like a great time to load up, while the market is still "deaf" to RVX ... and before a giant mushroom cloud of Benjamens forms over Calgary.